全文获取类型
收费全文 | 32860篇 |
免费 | 2066篇 |
国内免费 | 213篇 |
专业分类
耳鼻咽喉 | 200篇 |
儿科学 | 870篇 |
妇产科学 | 768篇 |
基础医学 | 5157篇 |
口腔科学 | 859篇 |
临床医学 | 2655篇 |
内科学 | 8147篇 |
皮肤病学 | 617篇 |
神经病学 | 3279篇 |
特种医学 | 797篇 |
外国民族医学 | 2篇 |
外科学 | 2771篇 |
综合类 | 106篇 |
一般理论 | 11篇 |
预防医学 | 2834篇 |
眼科学 | 563篇 |
药学 | 2469篇 |
中国医学 | 148篇 |
肿瘤学 | 2886篇 |
出版年
2024年 | 23篇 |
2023年 | 265篇 |
2022年 | 536篇 |
2021年 | 1103篇 |
2020年 | 655篇 |
2019年 | 924篇 |
2018年 | 1119篇 |
2017年 | 783篇 |
2016年 | 963篇 |
2015年 | 1043篇 |
2014年 | 1369篇 |
2013年 | 1751篇 |
2012年 | 2816篇 |
2011年 | 2882篇 |
2010年 | 1517篇 |
2009年 | 1376篇 |
2008年 | 2272篇 |
2007年 | 2229篇 |
2006年 | 2075篇 |
2005年 | 1820篇 |
2004年 | 1607篇 |
2003年 | 1489篇 |
2002年 | 1306篇 |
2001年 | 328篇 |
2000年 | 257篇 |
1999年 | 286篇 |
1998年 | 252篇 |
1997年 | 205篇 |
1996年 | 187篇 |
1995年 | 124篇 |
1994年 | 111篇 |
1993年 | 126篇 |
1992年 | 146篇 |
1991年 | 115篇 |
1990年 | 106篇 |
1989年 | 101篇 |
1988年 | 85篇 |
1987年 | 82篇 |
1986年 | 82篇 |
1985年 | 65篇 |
1984年 | 72篇 |
1983年 | 49篇 |
1982年 | 41篇 |
1981年 | 45篇 |
1980年 | 38篇 |
1979年 | 37篇 |
1978年 | 27篇 |
1975年 | 22篇 |
1974年 | 27篇 |
1973年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Alessia Scarselli Silvia Di Cesare Claudia Capponi Simona Cascioli Maria L. Romiti Gigliola Di Matteo Alessandra Simonetti Paolo Palma Andrea Finocchi Barbarella Lucarelli Rita M. Pinto Ippolita Rana Giuseppe Palumbo Maurizio Caniglia Paolo Rossi Rita Carsetti Caterina Cancrini Alessandro Aiuti 《Journal of clinical immunology》2015,35(4):373-383
6.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
7.
José Antonio Pereira Miguel Pera Manuel López-Cano Marta Pascual Sandra Alonso Silvia Salvans Marta Jiménez-Toscano Alba González-Martín Luis Grande-Posa 《Cirugía espa?ola》2019,97(1):20-26
Objectives
To determine the incidence of incisional hernia (IH) in the extraction incision (EI) in colorectal resection for cancer. To analyze whether the location of the incision has any relationship with the incidence of hernias and whether mesh could be useful for prevention in high-risk patients.Methods
Retrospective review of the colon and rectal surgery database from January 2015 to December 2016. Data were classified into 2 groups, transverse (TI) and midline incision (MI), and the latter was divided into 2 subgroups (mesh [MIM] and suture [MIS]). Patients were classified using the HERNIAscore. Hernias were diagnosed by clinical and/or CT examination.Results
A total of 182 out of 210 surgical patients were included. After a median follow-up of 13.0 months, 39 IH (21.9%) were detected, 23 of which (13.4%) were in the EI; their frequency was lower in the TI group (3.4%) and in the MIM group (5.9%) than in the MIS group (29.5%; p = 0.007). The probability of developing IH in the MIS group showed an OR = 11.7 (95%CI: 3.3-42.0) compared to the TI group and 4.3 (IC 95%: 1.1-16.3) versus the MIM group.Conclusions
The location of the incision is relevant to avoid incisional hernias. Transverse incisions should be used as the first option. When a midline incision is needed, a prophylactic mesh could be considered in high risk patients because it is safe and associated with low morbidity. 相似文献8.
Li Sun Zia Sadique Isabel dos-Santos-Silva Li Yang Rosa Legood 《International journal of cancer. Journal international du cancer》2019,144(10):2596-2604
In low and middle-income countries mammographic breast cancer screening is prohibitively expensive and a cheaper alternative option is to use ultrasound as the primary screening test. In 2009, China launched a breast cancer screening programme for rural women aged 35–64 years with clinical breast examination coupled with ultrasound as the primary tool. Our study aimed to analyse the cost-effectiveness of breast screening compared to no screening among Chinese rural women. We developed a Markov model to estimate the lifetime costs and effects for rural women aged 35 years from a societal perspective. Asymptomatic women in the intervention arm were screened every 3 years before age 64 years. Breast cancer in the non-screening arm can only be diagnosed on presentation of symptoms. Parameter uncertainty was explored using one-way and probabilistic sensitivity analyses. Compared to no screening, breast cancer screening cost $186.7 more and led to a loss of 0.20 quality-adjusted life years (QALYs). Breast screening was more expensive and did harm to health among rural women with an incremental cost-effectiveness ratio (ICER) of $-916/QALY. The sensitivity analysis identified utility loss from false positives as the factor that most influenced the results, but this did not affect the conclusions. In a rural setting with such low breast cancer incidence, screening for asymptomatic disease is not cost-effective with current screening tools. Priority should be given to ensure that symptomatic women have proper access to diagnosis and treatment at an early stage as this will lead to mortality reductions without the usual screening harms. 相似文献
9.
10.
Stefan Scholz Florian Koerber Kinga Meszaros Rosa Maya Fassbender Bernhard Ultsch Robert R. Welte Wolfgang Greiner 《Vaccine》2019,37(12):1692-1701